ClinicalTrials.govpublic full text
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Sjogren's Syndrome
sjogren's syndrome, autoimmune diseases, cd19 car t-cell therapy, bcma car t-cell therapy, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 805975
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.